FDA Approved: CYSTARAN — Supplemental Application (Leadiant Biosciences, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for CYSTARAN (cysteamine hydrochloride) from Leadiant Biosciences, Inc., indicating an approved change related t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephropathic Cystinosis

Drugs mentioned

• Cystaran (cysteamine hydrochloride)

Snippet

SUPPL AP for CYSTARAN (CYSTEAMINE HYDROCHLORIDE)